Canada’s legal cannabis industry has experienced significant growth in the past few years. For those interested in investing in cannabis, a slew of marijuana companies have broken into the big leagues of market trading to become TSX cannabis stocks.

The TSX offers a new venue for cannabis ventures, and big names in the cannabis industry have made the cut, including massive licensed producers expanding their product offerings and brands.

These companies are leaders in the industry thanks to their rapid growth and large-scale developments.

For those interested in how to invest in cannabis, here the Investing News Network offers a growing list of all the cannabis-related companies listed on the TSX in alphabetical order.

Alcanna (TSX:CLIQ,OTC Pink:LQSIF)

Alcanna is an alcohol retail operator first and foremost, but thanks to an investment from Aurora Cannabis (TSX:ACB,NYSE:ACB), the company now also manages marijuana retail shops across the country under the retail brand name Nova Cannabis.

Aleafia Health (TSX:ALEF,OTCQX:ALEAF)

After completing a key acquisition, the firm was able to reach the TSX and gain a spot amid some of the top cannabis producers in Canada. Aleafia Health has a direct focus on the health and wellness space and its relationship with cannabis products.

Aphria (TSX:APHA,NYSE:APHA)

Aphria was one of the first cannabis companies to reach the TSX and help solidify the growth of the marijuana industry. After undergoing a management change, the firm has maintained attention to its scale by growing its operations and international ventures.

Aurora Cannabis

Aurora Cannabis has secured a spot among the leading producers of marijuana in Canada, and has operations across the globe. The company has continued a steady path of acquisitions for players involved in all parts of the supply chain and development of marijuana technology.

Avicanna (TSX:AVCN,OTCQX:AVCNF)

Avicanna is a Canadian company working on the development of plant-derived cannabinoid-based products. The two subsidiaries of the company are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids.

Canopy Growth (TSX:WEED,NYSE:CGC)

Canopy Growth is one of the largest leading Canadian cannabis producers, with investments across the entire sector. The firm has a significant investment from alcohol-maker Constellation Brands (NYSE:STZ).

Canopy Rivers (TSX:RIV,OTC Pink:CNPOF)

As a venture capital firm specializing in cannabis, TSX cannabis stock Canopy Rivers invests in innovators across the marijuana value chain.

Cardiol Therapeutics (TSX:CRDL,OTCQX:CRTPF)

Cardiol Therapeutics is working on the development of medicines based on pharmaceutical-grade cannabidiol (CBD) and refining the production of lab-made elements of cannabis for medical use.

Charlotte’s Web Holdings (TSX:CWEB,OTCQX:CWBHF)

This Colorado-based company operates as a hemp producer distributing novelty products in the legal US market. Shares of Charlotte’s Web Holdings reached the TSX after regulators gained more clarity on the legal status of hemp in the US.

Cronos Group (TSX:CRON,NASDAQ:CRON)

Cronos Group is a leading marijuana firm with a blockbuster investment deal from Altria Group (NYSE:MO), one of the biggest tobacco producers in the world. The firm, like many other producers, has expressed interest in entering the US cannabis market at an appropriate time.

Delta 9 Cannabis (TSX:DN,OTCQX:VRNDF)

TSX cannabis stock Delta 9 Cannabis is a vertically integrated cannabis company selling cannabis products through its wholesale and retail sales channels.

Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF)

Fire & Flower Holdings is a licensed cannabis retailer that owns cannabis retail store licences in the Canadian provinces of Alberta, Saskatchewan, Manitoba and Ontario, as well as the Yukon.

HEXO (TSX:HEXO,NYSEAMERICAN:HEXO)

Similar to its producer peers, HEXO was able to secure a partnership with an established beverage maker to develop cannabis-infused drinks, thanks to a joint venture with Molson Coors Brewing Company (NYSE:TAP).

InMed Pharmaceuticals (TSX:IN,NASDAQ:INM)

InMed Pharmaceuticals operates as a biopharmaceutical company, but its focus is set on the development of CBD-based therapeutics for disease treatment. Its pipeline has three candidates.

MediPharm Labs (TSX:LABS,OTCQX:MEDIF)

MediPharm Labs, another TSX cannabis stock, is a cannabis extraction company working on offering pharmaceutical-grade cannabis oils and concentrates to be used for infused products. The firm expects to process 250,000 kilograms of dry cannabis per year for extraction.

Neptune Wellness Solutions (TSX:NEPT,NASDAQ:NEPT)

Neptune Wellness Solutions is a company working in the extraction market alongside the marijuana space for novelty products. The firm also produces cannabis capsules using Licaps technology.

OrganiGram Holdings (TSX:OGI,NASDAQ:OGI)

Organigram Holdings is a leading Canadian licensed producer of high-quality medical and recreational cannabis. Outside Canada, it is developing international partnerships to extend its global footprint.

The Green Organic Dutchman (TGOD) (TSX:TGOD,OTCQX:TGODF)

After a successful capital raising, TGOD reached the TSX with promises of organic cannabis production and cost-effective operations. It touts an international portfolio with operations in Europe and Latin America.

The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF)

The Supreme Cannabis Company has earned a reputation as a dedicated producer whose operations are growing at a steady scale. This company has a focus on brand development and an interest in international plays for the cannabis market.

The Valens Company (TSX:VLNS,OTCQX:VLNCF)

The Valens Company is a vertically integrated provider of cannabis products, and is well positioned to become a leader in the emerging global-wide cannabis nutraceuticals market, which includes cannabis oils, extracts, beverages and edibles.

Village Farms International (TSX:VFF,NASDAQ:VFF)

TSX cannabis stock Village Farms International is a vertically integrated greenhouse grower across North America. The company decided to enter the cannabis space through a 50/50 joint venture for the management of cannabis grower Pure Sunfarms.

VIVO Cannabis (TSX:VIVO,OTCQX:VVCIF)

VIVO Cannabis is a Canadian licensed producer of medical and recreational cannabis.

Zenabis Global (TSX:ZENA)

The resulting company from a reverse takeover between Sun Pharm Investments and Bevo Agro, this cannabis producer offers consumers a variety of recreational products.


INNdepth

Want more details on Canadian cannabis stocks? Check out these articles for more INNdepth coverage:

Want an overview of investing in cannabis? Check out Investing in the Cannabis Industry


Did we miss any marijuana companies that you think should be included on this list of cannabis stocks on the TSX? Let us know in the comments!

This is an updated version of an article first published by the Investing News Network in 2018. 

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Cardiol Therapeutics is a client of the Investing News Network. This article is not paid-for content.

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) Is pleased to announce its partially owned subsidiary NeonMind (CSE: NEON) (“NeonMind”) has common shares now trading on the Frankfurt Stock Exchange (the “FSE”) under the symbol “6UF”. As a result, NeonMind’s common shares are now cross-listed on the Canadian Securities Exchange and the FSE. Shares of Better Plant are available on the FSE under the symbol “YG3”.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/72301_betterplanta.jpg

Keep reading... Show less

Chemesis International Inc. (the “Company”) (CSE: CSI) (OTC: CADMF) (FRA: CWAA) is pleased to announce that all matters submitted to the shareholders of the Company at the Annual General and Special Meeting of the Company’s shareholders held on December 31, 2020 were approved.
In addition, the Company has granted, pursuant to its Equity Incentive Plan, options to purchase 1,500,000 shares of the Company exercisable for a period of 5 years at USD$0.70 per share to the directors, officers and consultants of the Company. The Company has also granted, pursuant to its Equity Incentive Plan, restricted share rights to acquire 1,500,000 shares of the Company to the directors, officers and consultants of the Company. One-half of such restricted share rights shall vest in three months from the grant date and the remaining one-half shall vest in six months from the grant date.
On Behalf of The Board of Directors
Josh Rosenberg
President
Investor Relations:
ir@chemesis.com
1 (604) 398-3378
The CSE has not reviewed, approved or disapproved the content of this press release

Source

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis extractor, announced today that the Canadian Intellectual Property Office has granted the Company a patent for the acetylation of cannabinoids. More specifically, the patent covers a process for acetylating cannabidiol (“CBD”), and subsequent refinement of CBD-O-Acetate using a proprietary extraction and distillation technique.

Keep reading... Show less

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) The Company announces that it has recently negotiated an extension to its option to purchase another 21% of Arcology for another year by an investment of $1,000,000. If the company exercises that option, it would then own 51

The Company is clarifying that in its press release of January 15th regarding the signing of a definitive agreement to acquire bit mining infrastructure, that the first phase will deliver 9,450 terahash per second, not 9,450 petahash as stated.

Keep reading... Show less

Appointment of Philip Young as CEO and director adds a seasoned executive with a track record of new device and therapeutics development, FDA/regulatory approvals, capital markets, M&A and operational success

 Lobe Sciences Ltd (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Mr. Philip J. Young as Chief Executive Officer, Corporate Secretary and a director of the Company, effective January 15, 2021. Mr. Young replaces Thomas Baird, who resigned as CEO as of the same date.

Keep reading... Show less